Current interim report on the development of ASV - 38 treatment teams for lung and thoracic tumors

17.05.2022 11:16

A total of 38 multidisciplinary treatment teams have so far treated 6,119 adult patients nationwide with lung tumors and other thoracic tumors per quarter. This is the current interim report of the Federal Joint Committee (G-BA) on the development of outpatient specialist medical care (ASV), which presents the development of ASV teams and patient numbers until the end of March 2022. The still young ASV offer for lung and thoracic tumors has been available since April 2020.

There are now 19 ASV offers for complex, rare and difficult-to-treat diseases. For the treatment of gastrointestinal tumors and tumors of the abdominal cavity, there is by far the largest ASV offering with 166 teams, followed by the ASV gynecological tumors with 111 teams nationwide. The ASV for rheumatism is in greatest demand from patients, with 476,828 affected adults and 3,205 children. There are still comparatively few offers for them; 63 teams are available for adults and 8 for children with rheumatism. The regional distribution of ASV offers is still heterogeneous, as the colored maps in the report show: In Mecklenburg-Western Pomerania, for example, the ASV has not yet been established at all. The federal state with the most ASV teams and patients is North Rhine-Westphalia.

The G-BA always prepares interim reports like this one for the Federal Ministry of Health two years after new ASV offers on cancer and rheumatic diseases come into force.